PHARMAGEST INTER. Stock Euronext Paris
Stocks
FR0000077687
IT Services & Consulting
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 04-30 | French and Benelux stocks-Factors to watch | RE |
| 04-30 | Equasens Q1 revenue at 61.4 million euros | RE |
| Market Cap | 529M 606M 489M 457M 858M 57.22B 864M 5.82B 2.26B 28.13B 2.27B 2.22B 97.74B | P/E 2025 * |
14.3x | P/E 2026 * | 11.5x |
|---|---|---|---|---|---|
| Enterprise Value | 434M 497M 401M 375M 703M 46.94B 709M 4.77B 1.86B 23.08B 1.86B 1.82B 80.17B | EV / Sales 2025 |
2.86x | EV / Sales 2026 * | 1.65x |
| Free-Float |
31.97% | Yield 2025 * |
3.97% | Yield 2026 * | 4.64% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 22/04/2022 | |
| Director of Finance/CFO | - | 01/01/2023 | |
Damien Maringer
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Chapusot
CHM | Chairman | 67 | 01/01/2010 |
| Director/Board Member | 61 | 01/01/2009 | |
Daniel Antoine
BRD | Director/Board Member | 74 | 01/01/2002 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.25% | -6.14% | -12.78% | +92.28% | 234B | ||
| +0.13% | -1.55% | -38.07% | -34.69% | 81.48B | ||
| -2.45% | -5.89% | +6.03% | +26.87% | 80.51B | ||
| -2.46% | -24.51% | -57.68% | -59.37% | 78.32B | ||
| -2.06% | -6.58% | -40.29% | -10.46% | 55.4B | ||
| +1.33% | -4.57% | -34.35% | -18.01% | 45.09B | ||
| -0.72% | -2.21% | -6.51% | +72.74% | 34.54B | ||
| -0.11% | +1.88% | -35.03% | -3.41% | 32.45B | ||
| -0.11% | -3.27% | -8.35% | +171.49% | 30.89B | ||
| Average | -0.23% | -5.68% | -25.23% | +26.38% | 74.76B | |
| Weighted average by Cap. | +0.97% | -7.51% | -23.08% | +33.59% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 236M 270M 218M 204M 382M 25.52B 385M 2.59B 1.01B 12.55B 1.01B 992M 43.58B | 260M 298M 241M 225M 421M 28.12B 425M 2.86B 1.11B 13.83B 1.12B 1.09B 48.03B |
| Net income | 37.1M 42.46M 34.32M 32.03M 60.13M 4.01B 60.57M 408M 159M 1.97B 159M 156M 6.85B | 44.5M 50.93M 41.16M 38.42M 72.12M 4.81B 72.65M 489M 190M 2.37B 191M 187M 8.22B |
| Net Debt | -95.08M -109M -87.94M -82.08M -154M -10.28B -155M -1.05B -407M -5.06B -409M -400M -17.56B | -101M -115M -93.05M -86.85M -163M -10.88B -164M -1.11B -430M -5.35B -432M -423M -18.58B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
















